Multiple myeloma is a type of cancer that affects plasma cells in the bone marrow. The ICD-10 code for multiple myeloma is C90.00. In the previous coding system, ICD-9, the code for multiple myeloma is 203.00. These codes are used for medical billing and classification purposes.
Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell responsible for producing antibodies. The ICD-10 code for multiple myeloma is C90.0. This code specifically refers to multiple myeloma, not other types of plasma cell neoplasms.
In the previous coding system, ICD-9, multiple myeloma was assigned the code 203.0. However, it is important to note that ICD-9 codes are no longer used for medical billing and documentation purposes, as they have been replaced by ICD-10 codes.
Multiple myeloma is characterized by the abnormal growth of plasma cells in the bone marrow, leading to the production of excess monoclonal antibodies. This condition can cause bone pain, fractures, anemia, kidney problems, and increased susceptibility to infections. It is typically diagnosed through blood tests, bone marrow biopsy, and imaging studies.
Treatment for multiple myeloma may include chemotherapy, targeted therapy, stem cell transplantation, and supportive care measures. The prognosis for multiple myeloma varies depending on various factors such as the stage of the disease, the patient's overall health, and response to treatment. Regular follow-up and monitoring are crucial for managing the condition effectively.